Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
Aim: Kidney impairment is observed in patients with COVID-19. The effect of anti-COVID-19 agent remdesivir on kidneys is currently unknown. We aimed to determine the effect of remdesivir on renal fibrosis and its downstream mechanisms.Methods: Remdesivir and its active nucleoside metabolite GS-44152...
Saved in:
Main Authors: | Lin Xu (Author), Bo Tan (Author), Di Huang (Author), Meijie Yuan (Author), Tingting Li (Author), Ming Wu (Author), Chaoyang Ye (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway
by: Pinglan Lin, et al.
Published: (2023) -
Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A
by: Ming Wu, et al.
Published: (2022) -
Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis
by: Di Huang, et al.
Published: (2022) -
A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
by: Yurou Chen, et al.
Published: (2022) -
Correlation of renal oxygenation with renal function in chronic kidney disease: a preliminary prospective study
by: Yizeng Xu, et al.
Published: (2023)